Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II pilot study of Hylase Dessau for correction of hyaluronic acid filler overcorrection
2019-001151-40Phase 2Terminated
- Sponsor
- RIEMSER
- Start
- Apr 2019
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of hyaluronidase in None, sponsored by RIEMSER. Primary endpoint: Determination of effective Hylase dose. Started Apr 2019; status: terminated.
02
Drugs
hyaluronidase
Beyond the preview
Go deeper on 2019-001151-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001151-40.